Cargando…
Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis
We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064885/ https://www.ncbi.nlm.nih.gov/pubmed/15642147 http://dx.doi.org/10.1186/ar1457 |